Breakwater Capital Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
MSV
VWM
SIS
QPBE
FFA
RT
WF
AAA
ACM
Breakwater Capital Group's PFE Position: Q3 2026 in Review
Breakwater Capital Group reduced its Pfizer (PFE) stake by 22% in Q3 2026, selling an estimated $394K and leaving 52,094 shares worth $1.49M. The position accounts for 0.18% of the portfolio, ranked #124.
Breakwater Capital Group first reported a position in PFE in Q4 2022 and has held it in 16 quarters since. The position peaked at $2.33M in Q3 2024. 156 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Breakwater Capital Group held 52,094 shares of Pfizer worth $1.49M as of Q3 2026.
- Breakwater Capital Group sold 14,817 Pfizer shares in Q3 2026, an estimated $394K.
- Pfizer made up 0.18% of Breakwater Capital Group's portfolio in Q3 2026, its #124 holding.
- Breakwater Capital Group first reported a position in Pfizer in Q4 2022 and has held it in 16 quarters since.
- Breakwater Capital Group's Pfizer position peaked at $2.33M in Q3 2024.
- 156 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Breakwater Capital Group's 13F filing for Q3 2026, filed 9 Oct 2026.